Site intended for healthcare professionals only
The long-term oncological outcomes of laparoscopic (LRC) and robotic-assisted radical cystectomy (RARC) are still maturing compared with open radical cystectomy (ORC).To evaluate the 5-yr oncological outcomes of patients recruited into […]
» Read moreSacral neuromodulation and intradetrusor injection of onabotulinumtoxinA are therapies for refractory urgency-urinary incontinence. Sacral neuromodulation involves surgical implant of a device that can last 4-6 years, while onabotulinumtoxinA involves serial […]
» Read moreThe use of Onabotulinum Toxin A (BTX) to chemically denervate the testis has been studied as a minimally invasive therapy to treat chronic scrotal pain (CSP). To date no randomized […]
» Read moreTo assess sperm chromatin fragmentation (SCF) at different levels of the male genital tract.Ejaculated specimens from consenting male partners were screened for SCF by terminal deoxynucleotidyl dUTP nick-end labeling (TUNEL). […]
» Read moreUrinary stone disease during pregnancy is poorly understood but is thought to be associated with increased maternal and fetal morbidity. We sought to determine the prevalence of urinary stone disease […]
» Read moreTo determine whether gene products from spermatogenic cells can be detected in Sertoli cell only (SCO) testes, transcriptome analysis using next-generation sequencing (NGS) was performed using human testicular samples.This study […]
» Read moreThe majority of patients with overactive bladder (OAB) are aged >65yr. There has been no prospectively designed study assessing treatment efficacy with the β3-adrenoreceptor agonist, mirabegron, specifically in this age […]
» Read moreIn the randomized, open-label, phase 3 CheckMate 214 trial, nivolumab plus ipilimumab (nivolumab 3 mg/kg plus ipilimumab 1 mg/kg every 3 wk for four doses, then nivolumab 3 mg/kg every 2 wk) had […]
» Read moreUrinary incontinence (UI) and fecal incontinence (FI) are common disorders in women that negatively impact quality of life. In addition to known health and lifestyle risk factors, genetics may play […]
» Read moreThe importance of local failure (LF) after treatment of high-grade prostate cancer (PCa) with definitive radiotherapy (RT) remains unknown.To evaluate the clinical implications of LF after definitive RT.Individual patient data […]
» Read moreTo expand the current prediction tools for lymph node invasion (LNI) in prostate cancer (PCa) patients with today’s state-of-the-art available tumor information, including multiparametric MRI (mpMRI)-based tumor (T) staging and […]
» Read more
